So-Young International Stock Rallies 49.82% on Four-Day Surge as Aesthetic Revenue Grows 426% YoY

The share price rose to its highest level so far this month, with an intraday gain of 24.43% on Nov. 7, marking a four-day rally that lifted the stock 49.82% in four sessions.

So-Young International’s surge follows a strategic shift toward aesthetic treatment services, which generated 426% year-over-year revenue growth in Q2 2025, surpassing non-core segments like advertising. The company now operates 29 branded aesthetic centers across nine Chinese cities, with 25 achieving positive monthly operating cash flow. This operational expansion, combined with a 314% six-month stock price gain, underscores investor confidence in its vertical integration model, which merges online discovery with offline treatment delivery.

Regulatory compliance also bolstered sentiment. The stock regained Nasdaq’s minimum bid price requirement in July 2025, resolving a delisting risk that had persisted since August 2024. Meanwhile, mixed analyst ratings reflect uncertainty around short-term earnings—Q3 2025 guidance projects $0.05 negative EPS—but long-term optimism persists, with a $5.78 average price target implying 64% upside. The company’s upcoming Nov. 17 earnings report and Q4 guidance will be critical in sustaining momentum amid regulatory scrutiny of China’s medical aesthetics sector.